Adamas Pharmaceuticals Inc (ADMS) Stock Analyst Earnings Estimates
NASDAQ:ADMS - Nasdaq - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 34.05M 5,873.68% | 54.64M 60.47% | 74.46M 36.27% | 96.04M 28.98% | 128.207M 33.49% | 137.633M 7.35% | 162.492M 18.06% | 195.677M 20.42% | |
| EBITDA YoY % growth | -113.56M -30.92% | -91.03M 19.84% | -43.31M 52.42% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -115.02M -30.81% | -92.24M 19.81% | -44.16M 52.12% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | -337.80% | -168.81% | -59.31% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -4.89 -23.48% | -3.80 22.29% | -2.02 46.84% | -1.04 48.66% | -0.36 64.81% | -0.18 51.20% | -0.28 -54.91% | -0.44 -58.00% |
| Q4 / 21 | Q1 / 22 | Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.18 72.02% | -0.17 53.72% | -0.13 53.41% | -0.07 70.29% | -0.03 82.91% | -0.13 20.41% | -0.05 59.46% | 0.02 130.00% | 0.10 433.33% |
| Revenue Q2Q % growth | 28.516M 35.72% | 28.889M 49.61% | 31.309M 42.49% | 34.262M 32.31% | 36.074M 26.51% | 30.395M 5.21% | 33.577M 7.25% | 37.665M 9.93% | 41.645M 15.44% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | 45.49% | -0.23 | % | |
| Q2 2021 Q2Q % growth | -0.27 27.03% | -0.30 | 0.03 | 9.76% |
| Q1 2021 Q2Q % growth | -0.36 38.98% | -0.52 | 0.16 | 30.80% |
| Q4 2020 Q2Q % growth | -0.64 22.89% | -0.52 | -0.12 | -21.97% |
| Q3 2020 Q2Q % growth | -0.42 57.58% | -0.49 | 0.07 | 14.41% |
| Q2 2020 Q2Q % growth | -0.37 58.89% | -0.62 | 0.25 | 40.56% |
| Q1 2020 Q2Q % growth | -0.59 45.37% | -0.79 | 0.20 | 25.00% |
| Q4 2019 Q2Q % growth | -0.83 | -0.87 | 0.04 | 4.41% |
| Q3 2019 Q2Q % growth | -0.99 | -0.91 | -0.08 | -8.57% |
| Q2 2019 Q2Q % growth | -0.90 | -1.00 | 0.10 | 10.04% |
| Q1 2019 Q2Q % growth | -1.08 | -1.17 | 0.09 | 7.57% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | 25.896M 28.33% | 25.263M | 632.507K | 2.50% |
| Q2 2021 Q2Q % growth | 21.972M 16.93% | 22.382M | -410.084K | -1.83% |
| Q1 2021 Q2Q % growth | 19.31M 33.36% | 20.417M | -1.107M | -5.42% |
| Q4 2020 Q2Q % growth | 21.01M 28.50% | 21.375M | -365.232K | -1.71% |
| Q3 2020 Q2Q % growth | 20.18M 44.87% | 21.367M | -1.187M | -5.55% |
| Q2 2020 Q2Q % growth | 18.79M 48.07% | 15.625M | 3.165M | 20.26% |
| Q1 2020 Q2Q % growth | 14.48M 24.08% | 15.434M | -954.263K | -6.18% |
| Q4 2019 Q2Q % growth | 16.35M | 16.004M | 346.2K | 2.16% |
| Q3 2019 Q2Q % growth | 13.93M | 14.349M | -419.136K | -2.92% |
| Q2 2019 Q2Q % growth | 12.69M | 13.143M | -452.578K | -3.44% |
| Q1 2019 Q2Q % growth | 11.67M | 12.558M | -888.352K | -7.07% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |